Blood Pressure Drugs Prevent Far More Heart Attacks and Strokes Than the Serious Falls They Cause, Study of 5.5 Million Finds
Oxford researchers found that for every 1,000 patients treated for 10 years, blood pressure drugs would prevent about eight serious heart attacks and strokes while causing about two serious falls, with the balance holding even for frail patients in their 80s.
Blood pressure drugs prevent far more serious heart attacks and strokes than the serious falls they cause, even in older patients and those living with frailty, according to a study of more than 5.5 million patients in England published in Nature Communications.
Researchers at the University of Oxford built a risk calculator, called STRATIFY-CVD, from anonymized NHS patient records and combined it with models of drug side effects and evidence from clinical trials. The records covered 5,578,002 patients aged 40 and older in the Clinical Practice Research Datalink between 1998 and 2018.

The team estimated that for every 1,000 patients treated over 10 years, blood pressure drugs would prevent about eight serious cardiovascular events, such as heart attacks and strokes, while causing about two serious falls.
The balance held for frail patients in their 80s
Doctors often hesitate to prescribe blood pressure drugs to frail older patients for fear of falls. The study found the balance still favored treatment in that group: treating 1,000 men in their 80s with moderate frailty for 10 years would prevent an estimated 47 serious cardiovascular events and cause nine serious falls. For fit men in their 60s with no history of cardiovascular disease, the figures were 12 events prevented and one fall caused.

“Deciding whether to prescribe blood pressure medication isn’t always straightforward, particularly when someone is older, living with frailty or several other health conditions,” said James Sheppard, a professor at Oxford’s Nuffield Department of Primary Care Health Sciences and the study’s senior author.
Other side effects were more evenly matched
The picture was less clear-cut for other side effects. For fainting and acute kidney injury, the benefits and harms of treatment were more finely balanced, according to the study. For low blood pressure and raised potassium levels, which can lead to heart palpitations and shortness of breath, the models suggested treatment could cause more adverse events than cardiovascular events prevented, though those side effects are generally less serious than a heart attack or stroke.

The study has limits. It is a modeling study, so its numbers are estimates built from health records and earlier trial results, not results from a trial that assigned patients at random to take the drugs or go without them. The records also came from patients in England.
STRATIFY-CVD estimates a person’s chance of a serious cardiovascular event over five to 10 years from age, medical history, existing conditions and medication use. The researchers said the tool could help doctors and patients weigh treatment choices for each person, and could inform future treatment guidelines.
Reporting based on coverage by MedicalXpress and Nature Communications.